The overlap of genetic susceptibility to schizophrenia and cardiometabolic disease can be used to identify metabolically different groups of individuals.

MLA

Strawbridge, Rona J., et al. “The Overlap of Genetic Susceptibility to Schizophrenia and Cardiometabolic Disease Can Be Used to Identify Metabolically Different Groups of Individuals.” Scientific Reports, vol. 11, no. 1, Jan. 2021, p. 632. EBSCOhost, https://doi.org/10.1038/s41598-020-79964-x.

APA

Strawbridge, R. J., Johnston, K. J. A., Bailey, M. E. S., Baldassarre, D., Cullen, B., Eriksson, P., deFaire, U., Ferguson, A., Gigante, B., Giral, P., Graham, N., Hamsten, A., Humphries, S. E., Kurl, S., Lyall, D. M., Lyall, L. M., Pell, J. P., Pirro, M., Savonen, K., … Smith, D. J. (2021). The overlap of genetic susceptibility to schizophrenia and cardiometabolic disease can be used to identify metabolically different groups of individuals. Scientific Reports, 11(1), 632. https://doi.org/10.1038/s41598-020-79964-x

Chicago

Strawbridge, Rona J, Keira J A Johnston, Mark E S Bailey, Damiano Baldassarre, Breda Cullen, Per Eriksson, Ulf deFaire, et al. 2021. “The Overlap of Genetic Susceptibility to Schizophrenia and Cardiometabolic Disease Can Be Used to Identify Metabolically Different Groups of Individuals.” Scientific Reports 11 (1): 632. doi:10.1038/s41598-020-79964-x.